Dale Nepert

  • Citations Per Year
Learn More
INTRODUCTION This trial assessed the safety and efficacy of LM in combination with carboplatin/etoposide therapy compared to carboplatin/etoposide treatment alone in patients with previously untreated extensive-disease small-cell lung cancer (ED-SCLC). PATIENTS AND METHODS A run-in phase 1 stage was used to determine the recommended phase 2 dose and(More)
  • 1